Hospital News and Research

RSS

Delaying rheumatoid arthritis treatment could greatly increase likelihood of joint damage

Delaying treatment for rheumatoid arthritis could greatly increase the likelihood that patients will suffer joint damage and experience disability two years out, according to a new study from Vivian Bykerk, M.D. at Hospital for Special Surgery. The research will be presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on October 28 in San Diego.

28 Oct 2013

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.

28 Oct 2013

Self-directed walking program shows promise in easing joint stiffness in older breast cancer patients

A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Socially isolated individuals more likely to experience ongoing pain following THR surgery

Researchers at Hospital for Special Surgery set out to test this hypothesis. They found that people who lacked good social ties were much more likely to experience serious, ongoing pain following total hip replacement surgery two or more years after the procedure.

28 Oct 2013

Apremilast drug shows promise for Behcet's ulcers

Apremilast, an orally available small molecule modulating several inflammatory pathways, which is pending approval by the United States Food and Drug Administration, is showing promise in the treatment of mouth and genital ulcers in people with Behcet's syndrome, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.

28 Oct 2013

DPP-4 inhibitors may reduce risk of autoimmune diseases

Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

The number of children and young adults with autoimmune diseases receiving the HPV vaccination is profoundly low despite studies showing the vaccine to be safe and effective, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. Given the increased incidence of HPV in people with autoimmune diseases, this research suggests that increased public health efforts are needed.

28 Oct 2013

Anti-tumor necrosis factor drugs modestly reduce risk of acute coronary syndrome

Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Rituximab drug may be safe, effective for immunoglobulin G4-related disease treatment

Rituximab (Rituxan) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener's), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Two aggressive therapy approaches effective for children with juvenile idiopathic arthritis

Children with juvenile idiopathic arthritis who receive early, aggressive therapy with a combination of medications achieve clinical inactive disease status faster than they would with less aggressive therapy, according to new research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

AAP offers new guidance on 'returning to learning' after concussion

A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.

28 Oct 2013

Study confirms the "seed and soil" theory of metastasis

Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.

28 Oct 2013

Researchers call for new education strategies to reinforce need for bike helmets among children

Despite a California bike helmet mandate, only 11 percent of Los Angeles County children treated for bike-related injuries were wearing a helmet, according to an abstract presented Oct. 26 at the American Academy of Pediatrics National Conference and Exhibition in Orlando.

28 Oct 2013

MRSA musculoskeletal infections increasing among children

Pediatric musculoskeletal Staphylococcus aureus bacterial infections have been evolving over the past decade, with more children diagnosed with the more virulent, methicillin-resistant Staphylococcus aureus today than 10 years ago.

28 Oct 2013

Stroke prevention study: Medication plus lifestyle changes safe, effective than surgical interventions

The final results of a stroke prevention study in patients with narrowed brain arteries confirm earlier findings: Medication plus lifestyle changes are safer and more effective at preventing stroke than a surgical technique called stenting.

28 Oct 2013

Study examines incidence of adverse drug events in hospitalized children

New research from a University Hospitals Rainbow Babies & Children's Hospital study found that children ages 1 to 3 years accounted for one-fifth of all emergency department visits caused by complications from asthma, representing the highest proportion of visits among asthma patients under age 21.

28 Oct 2013

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

28 Oct 2013

Powerful neodymium magnets cause 'significant' increase in pediatric ingestion-related injuries

The continued sale and availability of powerful, neodymium magnets-typically 10 to 20 times stronger than traditional magnets- are causing an increase in pediatric ingestion-related injuries, according to an abstract presented Sunday, Oct. 27, at the American Academy of Pediatrics National Conference and Exhibition in Orlando.

28 Oct 2013

Reducing the number of household firearms may reduce childhood gunshot injuries

There are approximately 7,500 child hospitalizations and 500 in-hospital deaths each year due to injuries sustained from guns. In an abstract presented Oct. 27 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando, researchers also identified a link between the percentage of homes with guns and the prevalence of child gunshot injuries.

28 Oct 2013

Biodesix presents additional VeriStrat Phase III trial data at World Conference on Lung Cancer

Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced additional data from the Phase III clinical trial for its serum protein test, VeriStrat. Results were presented at the 15th World Conference on Lung Cancer in Sydney, Australia.

28 Oct 2013

Hospital News and Research

Delaying rheumatoid arthritis treatment could greatly increase likelihood of joint damage

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Self-directed walking program shows promise in easing joint stiffness in older breast cancer patients

Socially isolated individuals more likely to experience ongoing pain following THR surgery

Apremilast drug shows promise for Behcet's ulcers

DPP-4 inhibitors may reduce risk of autoimmune diseases

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

Anti-tumor necrosis factor drugs modestly reduce risk of acute coronary syndrome

Rituximab drug may be safe, effective for immunoglobulin G4-related disease treatment

Two aggressive therapy approaches effective for children with juvenile idiopathic arthritis

AAP offers new guidance on 'returning to learning' after concussion

Study confirms the "seed and soil" theory of metastasis

Researchers call for new education strategies to reinforce need for bike helmets among children

MRSA musculoskeletal infections increasing among children

Stroke prevention study: Medication plus lifestyle changes safe, effective than surgical interventions

Study examines incidence of adverse drug events in hospitalized children

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

Powerful neodymium magnets cause 'significant' increase in pediatric ingestion-related injuries

Reducing the number of household firearms may reduce childhood gunshot injuries

Biodesix presents additional VeriStrat Phase III trial data at World Conference on Lung Cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News